1887
Research article Open Access
Like 0

Abstract

The extended-spectrum beta-lactamase (ESBL)-producing clone ST131 (ESBL-ST131) has spread in healthcare settings worldwide. The reasons for its successful spread are unknown, but might include more effective transmission and/or longer persistence. We evaluated the colonisation dynamics of ESBL-producing (ESBL-EC), including ESBL-ST131, in a long-term care facility (LTCF) with an unusually high prevalence of rectal ESBL-EC colonisation. During a 14-month period, rectal or faecal samples were obtained from 296 residents during six repetitive prevalence surveys, using ESBL-selective culture. Transmission rates, reproduction numbers, and durations of colonisation were compared for ESBL-ST131 vs other ESBL-EC. Furthermore, the likely time required for ESBL-ST131 to disappear from the LTCF was estimated. Over time, the endemic level of ESBL-ST131 remained elevated whereas other ESBL-EC returned to low-level prevalence, despite comparable transmission rates. Survival analysis showed a half-life of 13 months for ESBL-ST131 carriage, vs two to three months for other ESBL-EC (p < 0.001). Per-admission reproduction numbers were 0.66 for ESBL-ST131 vs 0.56 for other ESBL-EC, predicting a mean time of three to four years for ESBL-ST131 to disappear from the LTCF under current conditions. Transmission rates were comparable for ESBL-ST131 vs other ESBL-EC. Prolonged rectal carriage explained the persistence of ESBL-ST131 in the LTCF.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2016.21.42.30376
2016-10-20
2017-10-19
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2016.21.42.30376
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/21/42/eurosurv-21-30376-3.html?itemId=/content/10.2807/1560-7917.ES.2016.21.42.30376&mimeType=html&fmt=ahah

References

  1. Bush K. Extended-spectrum beta-lactamases in North America, 1987-2006. Clin Microbiol Infect. 2008;14(Suppl 1):134-43.  https://doi.org/10.1111/j.1469-0691.2007.01848.x  PMID: 18154537 
  2. Cantón R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, et al. Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect. 2008;14(Suppl 1):144-53.  https://doi.org/10.1111/j.1469-0691.2007.01850.x  PMID: 18154538 
  3. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42(Suppl 2):S82-9.  https://doi.org/10.1086/499406  PMID: 16355321 
  4. Tumbarello M, Spanu T, Di Bidino R, Marchetti M, Ruggeri M, Trecarichi EM, et al. Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-β-lactamase production and inadequate initial antibiotic therapy. Antimicrob Agents Chemother. 2010;54(10):4085-91.  https://doi.org/10.1128/AAC.00143-10  PMID: 20660675 
  5. Rodríguez-Baño J, López-Cerero L, Navarro MD, Díaz de Alba P, Pascual A. Faecal carriage of extended-spectrum β-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother. 2008;62(5):1142-9.  https://doi.org/10.1093/jac/dkn293  PMID: 18641033 
  6. Valverde A, Grill F, Coque TM, Pintado V, Baquero F, Cantón R, et al. High rate of intestinal colonization with extended-spectrum-β-lactamase-producing organisms in household contacts of infected community patients. J Clin Microbiol. 2008;46(8):2796-9.  https://doi.org/10.1128/JCM.01008-08  PMID: 18562591 
  7. Alsterlund R, Carlsson B, Gezelius L, Haeggman S, Olsson-Liljequist B. Multiresistant CTX-M-15 ESBL-producing Escherichia coli in southern Sweden: Description of an outbreak. Scand J Infect Dis. 2009;41(6-7):410-5.  https://doi.org/10.1080/00365540902896079  PMID: 19396721 
  8. Lautenbach E, Han J, Santana E, Tolomeo P, Bilker WB, Maslow J. Colonization with extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species in long-term care facility residents. Infect Control Hosp Epidemiol. 2012;33(3):302-4.  https://doi.org/10.1086/664055  PMID: 22314070 
  9. Jans B, Schoevaerdts D, Huang T-D, Berhin C, Latour K, Bogaerts P, et al. Epidemiology of multidrug-resistant microorganisms among nursing home residents in Belgium. PLoS One. 2013;8(5):e64908.  https://doi.org/10.1371/journal.pone.0064908  PMID: 23738011 
  10. Hilty M, Betsch BY, Bögli-Stuber K, Heiniger N, Stadler M, Küffer M, et al. Transmission dynamics of extended-spectrum β-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting. Clin Infect Dis. 2012;55(7):967-75.  https://doi.org/10.1093/cid/cis581  PMID: 22718774 
  11. Willemsen I, Nelson-Melching J, Hendriks Y, et al. Measuring the quality of infection control in Dutch nursing homes using a standardized method; the Infection prevention RIsk Scan (IRIS). Antimicrob Resist Infect Control. 2014;18(3):26.
  12. Overdevest I, Willemsen I, Rijnsburger M, Eustace A, Xu L, Hawkey P, et al. Extended-spectrum β-lactamase genes of Escherichia coli in chicken meat and humans, The Netherlands. Emerg Infect Dis. 2011;17(7):1216-22.  https://doi.org/10.3201/eid1707.110209  PMID: 21762575 
  13. Werkgroep infectiepreventie. Richtlijn: Bijzonder resistente micro-organismen (BRMO). [Guideline for highly resistant micro-organisms]. 2013. Dutch. Available from: http://www.rivm.nl/dsresource?objectid=rivmp:46410&type=org&disposition=inline&ns_nc=1
  14. Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, Peixe L, et al. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg Infect Dis. 2008;14(2):195-200.  https://doi.org/10.3201/eid1402.070350  PMID: 18258110 
  15. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother. 2011;66(1):1-14.  https://doi.org/10.1093/jac/dkq415  PMID: 21081548 
  16. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis. 2010;51(3):286-94.  https://doi.org/10.1086/653932  PMID: 20572763 
  17. Nicolas-Chanoine M-H, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Caniça MM, et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother. 2008;61(2):273-81.  https://doi.org/10.1093/jac/dkm464  PMID: 18077311 
  18. Banerjee R, Johnston B, Lohse C, Porter SB, Clabots C, Johnson JR. Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts. Infect Control Hosp Epidemiol. 2013;34(4):361-9.  https://doi.org/10.1086/669865  PMID: 23466908 
  19. van der Donk CFM, Schols JMGA, Driessen CJ, Hagenouw RGP, Meulendijks A, Stobberingh EE. Prevalence and spread of multidrug resistant Escherichia coli isolates among nursing home residents in the southern part of The Netherlands. J Am Med Dir Assoc. 2013;14(3):199-203.  https://doi.org/10.1016/j.jamda.2012.09.026  PMID: 23141211 
  20. EUCAST.org. [Internet]. European committee of antimicrobial susceptibility testing. [Accessed 1 Jan 2014]. Available from: http://www.eucast.org/clinical_breakpoints/
  21. Bernards AT, Bonten MJM, Cohen Stuart J, et al. NVMM Guideline - Laboratory detection of highly resistant microorganisms (HRMO). 2012. Available from: http://www.nvmm.nl/system/files/2012.11.15%20richtlijn%20BRMO%20(version%202.0)%20-%20RICHTLIJN.pdf
  22. Doumith M, Day MJ, Hope R, Wain J, Woodford N. Improved multiplex PCR strategy for rapid assignment of the four major Escherichia coli phylogenetic groups. J Clin Microbiol. 2012;50(9):3108-10.  https://doi.org/10.1128/JCM.01468-12  PMID: 22785193 
  23. Dhanji H, Doumith M, Clermont O, Denamur E, Hope R, Livermore DM, et al. Real-time PCR for detection of the O25b-ST131 clone of Escherichia coli and its CTX-M-15-like extended-spectrum β-lactamases. Int J Antimicrob Agents. 2010;36(4):355-8.  https://doi.org/10.1016/j.ijantimicag.2010.06.007  PMID: 20691573 
  24. Cohen Stuart J, Dierikx C, Al Naiemi N, Karczmarek A, Van Hoek AH, Vos P, et al. Rapid detection of TEM, SHV and CTX-M extended-spectrum β-lactamases in Enterobacteriaceae using ligation-mediated amplification with microarray analysis. J Antimicrob Chemother. 2010;65(7):1377-81.  https://doi.org/10.1093/jac/dkq146  PMID: 20462947 
  25. Cuzon G, Naas T, Bogaerts P, Glupczynski Y, Nordmann P. Evaluation of a DNA microarray for the rapid detection of extended-spectrum β-lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM). J Antimicrob Chemother. 2012;67(8):1865-9.  https://doi.org/10.1093/jac/dks156  PMID: 22604450 
  26. Savelkoul PHM, Aarts HJM, de Haas J, Dijkshoorn L, Duim B, Otsen M, et al. Amplified-fragment length polymorphism analysis: the state of an art. J Clin Microbiol. 1999;37(10):3083-91. PMID: 10488158 
  27. Diekman O, Heesterbeek H, Britton T, editors. Mathematical tools for understanding infectious disease dynamic. 1st Ed. Princeton (ND): Princeton university press; 2012.
  28. Tiengrim S, Thamlikitkul V. Inhibitory activity of fermented milk with Lactobacillus casei strain Shirota against common multidrug-resistant bacteria causing hospital-acquired infections. J Med Assoc Thai. 2012;95(Suppl 2):S1-5. PMID: 22574523 
  29. Singh R, van Nood E, Nieuwdorp M, van Dam B, ten Berge IJM, Geerlings SE, et al. Donor feces infusion for eradication of Extended Spectrum beta-Lactamase producing Escherichia coli in a patient with end stage renal disease. Clin Microbiol Infect. 2014;20(11):O977-8.  https://doi.org/10.1111/1469-0691.12683  PMID: 24845223 
  30. Oostdijk EAN, de Smet AMGA, Kesecioglu J, Bonten MJMDutch SOD-SDD Trialists Group. Decontamination of cephalosporin-resistant Enterobacteriaceae during selective digestive tract decontamination in intensive care units. J Antimicrob Chemother. 2012;67(9):2250-3.  https://doi.org/10.1093/jac/dks187  PMID: 22643189 
  31. Buehlmann M, Bruderer T, Frei R, Widmer AF. Effectiveness of a new decolonisation regimen for eradication of extended-spectrum β-lactamase-producing Enterobacteriaceae. J Hosp Infect. 2011;77(2):113-7.  https://doi.org/10.1016/j.jhin.2010.09.022  PMID: 21194789 
  32. Huttner B, Haustein T, Uçkay I, Renzi G, Stewardson A, Schaerrer D, et al. Decolonization of intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial. J Antimicrob Chemother. 2013;68(10):2375-82. PMID: 23719234 
  33. Alsterlund R, Axelsson C, Olsson-Liljequist B. Long-term carriage of extended-spectrum beta-lactamase-producing Escherichia coli. Scand J Infect Dis. 2012;44(1):51-4.  https://doi.org/10.3109/00365548.2011.592987  PMID: 21736509 
  34. Haverkate MR, Derde LPG, Brun-Buisson C, Bonten MJM, Bootsma MCJ. Duration of colonization with antimicrobial-resistant bacteria after ICU discharge. Intensive Care Med. 2014;40(4):564-71.  https://doi.org/10.1007/s00134-014-3225-8  PMID: 24522879 
  35. Apisarnthanarak A, Bailey TC, Fraser VJ. Duration of stool colonization in patients infected with extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis. 2008;46(8):1322-3.  https://doi.org/10.1086/533475  PMID: 18444877 
  36. Zahar JR, Lanternier F, Mechai F, Filley F, Taieb F, Mainot EL, et al. Duration of colonisation by Enterobacteriaceae producing extended-spectrum β-lactamase and risk factors for persistent faecal carriage. J Hosp Infect. 2010;75(1):76-8.  https://doi.org/10.1016/j.jhin.2009.11.010  PMID: 20227136 
  37. Barreto Miranda I, Ignatius R, Pfuller R, et al. High carriage rate of ESBL-producing Enterobacteriaceae at presentation and follow-up among travellers with gastrointestinal complaints returning from India and Southeast Asia. J Travel Med. 2016;23(2):Epub.
  38. Titelman E, Hasan CM, Iversen A, Nauclér P, Kais M, Kalin M, et al. Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors. Clin Microbiol Infect. 2014;20(8):O508-15.  https://doi.org/10.1111/1469-0691.12559  PMID: 24450760 
  39. Adler A, Gniadkowski M, Baraniak A, Izdebski R, Fiett J, Hryniewicz W, et al. MOSAR WP5 and WP2 study groups. Transmission dynamics of ESBL-producing Escherichia coli clones in rehabilitation wards at a tertiary care centre. Clin Microbiol Infect. 2012;18(12):E497-505.  https://doi.org/10.1111/j.1469-0691.2012.03999.x  PMID: 22963432 
/content/10.2807/1560-7917.ES.2016.21.42.30376
Loading

Data & Media loading...

Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error